Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Burnett

Showing results (61-70 of 438) with videos related to

Pageof 44
Sort By:
Expert Opinion on Investigational Drugs|June 26, 2012
Dalcetrapib , a cholesteryl ester transfer protein modulatorAmanda J Hooper, John R Burnett
Circulation. Cardiovascular Genetics|October 22, 2015
Finding the Therapeutic Sweet Spot: Using Naturally Occurring Human Variants to Inform Drug DesignJohn R Burnett, Robert A Hegele
Current Reviews in Musculoskeletal Medicine|December 26, 2024
Management of Horizontal Cleavage Meniscus TearsZachary R Burnett, David C Flanigan
Annals of Clinical Biochemistry|June 1, 2002
Cardiovascular disease and osteoporosis: is there a link between lipids and bone?John R Burnett, Samuel D Vasikaran
Free Radical Biology & Medicine|June 19, 2015
Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemiaJohn R Burnett, Amanda J Hooper
Applied Optics|January 16, 2010
Gravity-adjusted fabry-perot etalonC R Burnett, W E Lammer
Current Opinion in Lipidology|June 1, 1997
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretionM W Huff, J R Burnett
Expert Opinion on Therapeutic Targets|January 18, 2007
MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?John R Burnett, Gerald F Watts
The Journal of Prosthetic Dentistry|October 17, 2008
Anterior maxillary restoration using distraction osteogenesis and implants: a clinical reportWilliam E Dinse, Robert R Burnett
The Clinical Biochemist. Reviews|June 3, 2008
HDL revisited: new opportunities for managing dyslipoproteinaemia and cardiovascular diseaseGerald F Watts, John R Burnett
Pageof 44

Showing results (61-70 of 438) with videos related to

Sort By:
Pageof 44
Expert Opinion on Investigational Drugs|June 26, 2012
Dalcetrapib , a cholesteryl ester transfer protein modulatorAmanda J Hooper, John R Burnett
Circulation. Cardiovascular Genetics|October 22, 2015
Finding the Therapeutic Sweet Spot: Using Naturally Occurring Human Variants to Inform Drug DesignJohn R Burnett, Robert A Hegele
Current Reviews in Musculoskeletal Medicine|December 26, 2024
Management of Horizontal Cleavage Meniscus TearsZachary R Burnett, David C Flanigan
Annals of Clinical Biochemistry|June 1, 2002
Cardiovascular disease and osteoporosis: is there a link between lipids and bone?John R Burnett, Samuel D Vasikaran
Free Radical Biology & Medicine|June 19, 2015
Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemiaJohn R Burnett, Amanda J Hooper
Applied Optics|January 16, 2010
Gravity-adjusted fabry-perot etalonC R Burnett, W E Lammer
Current Opinion in Lipidology|June 1, 1997
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretionM W Huff, J R Burnett
Expert Opinion on Therapeutic Targets|January 18, 2007
MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?John R Burnett, Gerald F Watts
The Journal of Prosthetic Dentistry|October 17, 2008
Anterior maxillary restoration using distraction osteogenesis and implants: a clinical reportWilliam E Dinse, Robert R Burnett
The Clinical Biochemist. Reviews|June 3, 2008
HDL revisited: new opportunities for managing dyslipoproteinaemia and cardiovascular diseaseGerald F Watts, John R Burnett
Pageof 44